Investors Overview

Corporate Profile

Agios is a biopharmaceutical company that is fueled by connections. The strong bonds we build with patient communities, partners and colleagues enrich the impact we have as experts in cellular metabolism and enhance our collaboration, creativity and productivity – driving our ability to develop life-changing treatments for patients with genetically defined diseases.


Stock Information


Data Provided by Refinitiv. Minimum 15 minutes delayed.